Trial
NCT06692959
A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Southampton
Collaborators
Australasian Gastro-Intestinal Trials Group
Condition
Colorectal Cancer
Intervention
PD-1 vaccine IMU-201 (PD1-Vaxx)
Why stopped
funding withdrawal
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-24